Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine, Stanford, California, USA.
Department of Management Science and Engineering, Stanford University, Stanford, California, USA.
J Clin Endocrinol Metab. 2021 Oct 21;106(11):3239-3247. doi: 10.1210/clinem/dgab522.
Early initiation of continuous glucose monitoring (CGM) is advocated for youth with type 1 diabetes (T1D). Data to guide CGM use on time-in-range (TIR), hypoglycemia, and the role of partial clinical remission (PCR) are limited.
Our aims were to assess whether 1) an association between increased TIR and hypoglycemia exists, and 2) how time in hypoglycemia varies by PCR status.
We analyzed 80 youth who were started on CGM shortly after T1D diagnosis and were followed for up to 1-year post diagnosis. TIR and hypoglycemia rates were determined by CGM data and retrospectively analyzed. PCR was defined as (visit glycated hemoglobin A1c) + (4*units/kg/day) less than 9.
Youth were started on CGM 8.0 (interquartile range, 6.0-13.0) days post diagnosis. Time spent at less than 70 mg/dL remained low despite changes in TIR (highest TIR 74.6 ± 16.7%, 2.4 ± 2.4% hypoglycemia at 1 month post diagnosis; lowest TIR 61.3 ± 20.3%, 2.1 ± 2.7% hypoglycemia at 12 months post diagnosis). No events of severe hypoglycemia occurred. Hypoglycemia was rare and there was minimal difference for PCR vs non-PCR youth (54-70 mg/dL: 1.8% vs 1.2%, P = .04; < 54mg/dL: 0.3% vs 0.3%, P = .55). Approximately 50% of the time spent in hypoglycemia was in the 65 to 70 mg/dL range.
As TIR gradually decreased over 12 months post diagnosis, hypoglycemia was limited with no episodes of severe hypoglycemia. Hypoglycemia rates did not vary in a clinically meaningful manner by PCR status. With CGM being started earlier, consideration needs to be given to modifying CGM hypoglycemia education, including alarm settings. These data support a trial in the year post diagnosis to determine alarm thresholds for youth who wear CGM.
提倡在儿童 1 型糖尿病(T1D)患者中尽早开始持续血糖监测(CGM)。用于指导 CGM 目标范围内时间(TIR)、低血糖和部分临床缓解(PCR)的使用的数据是有限的。
我们的目的是评估:1)TIR 增加与低血糖之间是否存在关联,以及 2)PCR 状态对低血糖时间的影响。
我们分析了 80 名在 T1D 诊断后不久开始接受 CGM 监测并在诊断后 1 年内进行随访的青少年患者。通过 CGM 数据确定 TIR 和低血糖发生率,并进行回顾性分析。PCR 定义为(就诊时糖化血红蛋白 A1c)+(4*单位/公斤/天)<9。
青少年在诊断后 8.0(四分位距,6.0-13.0)天开始使用 CGM。尽管 TIR 发生变化,但<70mg/dL 的时间仍保持较低水平(诊断后 1 个月 TIR 最高时为 74.6±16.7%,低血糖为 2.4±2.4%;诊断后 12 个月 TIR 最低时为 61.3±20.3%,低血糖为 2.1±2.7%)。未发生严重低血糖事件。PCR 与非 PCR 青少年的低血糖均罕见(54-70mg/dL:1.8%比 1.2%,P=0.04;<54mg/dL:0.3%比 0.3%,P=0.55),差异无统计学意义。约有 50%的时间处于 65-70mg/dL 范围的低血糖状态。
随着 TIR 在诊断后 12 个月逐渐下降,低血糖也逐渐减少,且无严重低血糖发作。PCR 状态对低血糖发生率无明显影响。由于 CGM 更早开始,需要考虑修改 CGM 低血糖教育,包括报警设置。这些数据支持在诊断后 1 年内对使用 CGM 的青少年进行试验,以确定低血糖报警阈值。